Contact this trialFirst, we need to learn more about you.
Kinase Inhibitor
RET Inhibitor for Solid Cancers
Recruiting1 awardPhase 1 & 2
This trial is testing a new drug called TAS0953/HM06 for patients with advanced cancers that have specific genetic changes in the RET gene. The drug aims to block this gene to stop or slow down cancer growth. The initial part will find the safest dose, and the later part will test how well it works.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service